Which has the lower trailing P/E, ABT or DHR?

ABT has the lower trailing P/E: ABT trades at 33.96 and DHR at 34.84. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or DHR?

Over the past five years, ABT grew revenue faster — ABT at a 2.98% CAGR versus DHR at 1.97%.

Does ABT or DHR pay a bigger dividend?

ABT yields 2.31% and DHR yields 0.73% based on trailing dividends and the latest price.

Is ABT or DHR more profitable?

DHR runs the higher net margin — ABT at 11.65% versus DHR at 15.95%.

Abbott Laboratories (ABT) vs Danaher Corporation (DHR)

A side-by-side comparison of Abbott Laboratories and Danaher Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

ABT

Abbott Laboratories

$184.11B

$105.70HealthcareDelayed quote: Jul 31, 2026, 4:02 PM EDT

DHR

Danaher Corporation

$137.13B

$195.07HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

Total return — ABT vs DHR

growth of $100 · dividends reinvested · last 30y

ABT +1948.2%DHR +6465.5%DHR compounded faster

ABT DHR

ABT vs DHR: by the numbers

•ABT is the larger company ($184.11B vs $137.13B market cap).
•ABT trades at the lower trailing earnings multiple (33.96 vs 34.84 P/E), one valuation lens rather than an overall verdict.
•DHR converts more revenue to profit (15.95% vs 11.65% net margin).
•ABT grew revenue faster over the past five years (2.98% vs 1.97% CAGR).
•ABT pays the higher dividend yield (2.31% vs 0.73%).

Metrics side by side

Valuation

Metric	ABT	DHR
P/E ratio	33.96	34.84
Forward P/E	19.15	23.10
P/S ratio	3.95	5.53
P/B ratio	3.54	2.64
PEG ratio	4.13	87.11
EV / EBITDA	21.37	24.53
FCF yield	4.00%	3.94%

Profitability

Metric	ABT	DHR
Gross margin	56.80%	58.51%
Operating margin	17.03%	20.42%
Net margin	11.65%	15.95%
ROE	10.42%	7.61%
ROIC	8.43%	5.72%

Dividends

Metric	ABT	DHR
Dividend yield	2.31%	0.73%
Payout ratio	65.24%	28.40%

Growth (annualized)

Metric	ABT	DHR
Revenue CAGR (5Y)	2.98%	1.97%
EPS CAGR (5Y)	8.22%	0.40%
FCF CAGR (5Y)	5.26%	-2.83%
Total return CAGR (5Y)	-0.78%	-5.25%

Frequently asked

Which has the lower trailing P/E, ABT or DHR?: ABT has the lower trailing P/E: ABT trades at 33.96 and DHR at 34.84. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or DHR?: Over the past five years, ABT grew revenue faster — ABT at a 2.98% CAGR versus DHR at 1.97%.
Does ABT or DHR pay a bigger dividend?: ABT yields 2.31% and DHR yields 0.73% based on trailing dividends and the latest price.
Is ABT or DHR more profitable?: DHR runs the higher net margin — ABT at 11.65% versus DHR at 15.95%.

Go deeper

Full ABT analysis Full DHR analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Danaher P/E ratio Abbott Laboratories dividend yield Danaher dividend yield Abbott Laboratories ROE Danaher ROE Abbott Laboratories operating margin Danaher operating margin Abbott Laboratories revenue growth Danaher revenue growth Abbott Laboratories free cash flow Danaher free cash flow

Abbott Laboratories & Danaher appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.